Zevra Therapeutics
ZVRA
70 hedge funds and large institutions have $98.1M invested in Zevra Therapeutics in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 17 closing their positions.
346% more capital invested
Capital invested by funds: $22M → $98.1M (+$76.1M)
123% more call options, than puts
Call options by funds: $30.6M | Put options by funds: $13.7M
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
37% more funds holding
Funds holding: 51 → 70 (+19)
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
14.37% more ownership
Funds ownership: 8.26% → 22.63% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$20.5M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$7.77M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.31M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$4.74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.96M |
| 2 |
Jane Street
New York
|
-$1.72M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.39M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$678K |
| 5 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$615K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GSC
76
Ground Swell Capital
Folly Beach,
South Carolina
| – | -$131K | -14,219 | Closed |
|
77
UBS Group
Zurich,
Switzerland
| – | -$122K | -13,283 | Closed |
|
78
Group One Trading
Chicago,
Illinois
| – | -$141K | -13,163 | Closed |
|
79
Two Sigma Advisers
New York
| – | -$98K | -10,700 | Closed |
|
|
AA
80
Ancora Advisors
Cleveland,
Ohio
| – | -$2K | -218 | Closed |
|
|
QT
81
Quantbot Technologies
New York
| – | -$1K | -200 | Closed |
|
|
S
82
SignatureFD
Atlanta,
Georgia
| – | -$2K | -200 | Closed |
|
|
SPIA
83
Steward Partners Investment Advisory
New York
| – | -$1.84K | -200 | Closed |
|
|
WAP
84
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| – | -$1K | -100 | Closed |
|
85
Fidelity Investments
Boston,
Massachusetts
| – | +$43 | +4 | New |
|
ZVRA Hedge Fund Activity: Q2 2021 in Review
70 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Zevra Therapeutics (ZVRA) for Q2 2021, worth a combined $98.1M — up 346% from $22M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ZVRA positions and 17 closed out — a net gain of 19 holders — while 12 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $20.5M. The largest seller was Millennium Management, exiting entirely with an estimated $1.96M sold.
- 70 institutional investors held Zevra Therapeutics (ZVRA) as of Q2 2021, up from 51 in Q1 2021.
- Funds reported $98.1M of Zevra Therapeutics stock for Q2 2021, up 346% quarter-over-quarter.
- 36 funds opened new Zevra Therapeutics positions in Q2 2021 and 17 closed out, a net change of +19 holders.
- The largest Zevra Therapeutics buyer in Q2 2021 was BlackRock, an estimated $20.5M added.
- The largest Zevra Therapeutics seller in Q2 2021 was Millennium Management, an estimated $1.96M sold.
Based on aggregated 13F filings for Q2 2021.